Log In
BCIQ
Print this Print this
 

Sufentanil TDS

  Manage Alerts
Collapse Summary General Information
Company tesa SE
DescriptionMatrix-type transdermal patch with the active ingredient sufentanil, an opioid analgesic
Molecular Target Opioid receptor (OPR)
Mechanism of ActionOpioid receptor agonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationPain
Indication DetailsTreat chronic cancer pain
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today